Medical Science News

RSS

$145M Federal Government effort to harness power of nanotechnology to improve cancer patients

A $145-million Federal Government effort to harness the power of nanotechnology to improve the diagnosis, treatment, and prevention of cancer is producing innovations that will radically improve care for the disease. That's the conclusion of an update on the status of the program, called the National Cancer Institute Alliance for Nanotechnology in Cancer.

29 Apr 2010

Fluorescent inhibitors hold promise for early-stage tumor detection

A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers.

29 Apr 2010

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.

29 Apr 2010

Ancient skulls and bones reveal anatomy of human evolution

Ancient mummies, skulls and bones galore-Indiana Jones himself would learn a thing or two at the American Association of Anatomists' (AAA; www.anatomy.org) Annual Meeting beginning April 24, 2010 in Anaheim.

29 Apr 2010

Study: Curcumin nanoparticles limit toxicity of cancer therapy

Pre-treatment with curcumin, a component of the spice turmeric, makes ovarian cancer cells more vulnerable to chemotherapy and radiotherapy. Researchers writing in BioMed Central's open access Journal of Ovarian Research found that delivering the curcumin via very small (less than 100nm) nanoparticles enhanced the sensitizing effect.

29 Apr 2010

A new approach for treating neurological and degenerative disorders

In studies on cancer, heart disease, neurological disorders and other degenerative conditions, some scientists are moving away from the "nature versus nurture" debate, and are finding you're not a creature of either genetics or environment, but both - with enormous implications for a new approach to health.

29 Apr 2010

Celladon's first Phase II trial of MYDICAR for advanced heart failure meets primary endpoint

Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.

29 Apr 2010

NIH approves federal funding for 13 more stem cell lines

The Washington Post: Thirteen more lines of human embryonic stem cells are officially eligible for federal funding, since being approved by the National Institutes of Health. The Obama administration announced shortly after the President took office that restrictions would be lifted on the use of federal funds for embryonic stem cell research.

29 Apr 2010

Ceregene continues enrollment in new Phase 1/2 clinical study of CERE-120 for Parkinson's disease

Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.

29 Apr 2010

Tumor cell factories may be difficult to defeat: Researchers

Many of the colon cancer cells that form tumors can be killed by genetically short-circuiting the cells' ability to absorb a key nutrient, a new study has found. While the findings are encouraging, the test tube study using human colon cancer cells also illustrates the difficulty of defeating these cells, known as cancer stem cells.

29 Apr 2010

Subtle changes in PTEN protein levels increase chances of developing cancer

A US study has found that even subtle changes in the levels of PTEN, a protein that blocks cancer development, may significantly increase a person's chances of developing cancer.

28 Apr 2010

Scientists discover human DNA that act as a traitor to body's defences

Cancer Research UK-funded scientists have discovered that stretches of human DNA act as a traitor to the body's defences by helping viruses infect people and trigger cancer-causing diseases, according to a study published in Nature Cell Biology today.

28 Apr 2010

Stalk structure of Mx protein restrains components of influenza virus in infected cells

When the human body becomes infected with new influenza viruses, the immune system rapidly activates an inborn protective mechanism to inhibit the intruding pathogen. A protein known as Mx plays an important role in this process, keeping the spread of viruses in check. Exactly how Mx accomplishes this task was previously unknown.

28 Apr 2010

Research reveals therapeutic benefit of ACTH in treatment of osteonecrosis

Researchers at Mount Sinai School of Medicine have found a potential new treatment for osteonecrosis, or the death of bone tissue, in people who are treated with steroids for several common medical conditions. There are currently no treatment options for people with this debilitating disease. The research is published in the April 27 issue of Proceedings of the National Academy of Sciences.

28 Apr 2010

Researchers find Alzheimer's pathology to originate from Amyloid-Beta oligomers in the brain

Using a new mouse model of Alzheimer's disease, researchers at Mount Sinai School of Medicine have found that Alzheimer's pathology originates in Amyloid-Beta (Abeta) oligomers in the brain, rather than the amyloid plaques previously thought by many researchers to cause the disease.

28 Apr 2010

Study examines world-wide use of HSCT

An examination of the world-wide use of hematopoietic stem cell transplantation, which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.

28 Apr 2010

Potential new treatment for osteonecrosis

28 Apr 2010

Transplanted pig cells may bring relief from insulin injections in type I diabetics

Living Cell Technologies, a New Zealand based biotechnology company that is investigating the use of living pig cells in the treatment of diabetes has now received $700,000 (US$500,000) grant from the Juvenile Diabetes Research Foundation International for further human trials.

28 Apr 2010

NCCTG to conduct Phase II study of brostallicin in combination with cisplatin for mTNBC cancer

Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.

28 Apr 2010

Researchers link vitamin D deficiency to chronic fatigue in post-TBI sufferers

New evidence presented at the European Congress of Endocrinology has shown that vitamin D deficiency is closely associated with the chronic fatigue that often follows post traumatic brain injury.

28 Apr 2010

Medical Science News

$145M Federal Government effort to harness power of nanotechnology to improve cancer patients

Fluorescent inhibitors hold promise for early-stage tumor detection

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Ancient skulls and bones reveal anatomy of human evolution

Study: Curcumin nanoparticles limit toxicity of cancer therapy

A new approach for treating neurological and degenerative disorders

Celladon's first Phase II trial of MYDICAR for advanced heart failure meets primary endpoint

NIH approves federal funding for 13 more stem cell lines

Ceregene continues enrollment in new Phase 1/2 clinical study of CERE-120 for Parkinson's disease

Tumor cell factories may be difficult to defeat: Researchers

Subtle changes in PTEN protein levels increase chances of developing cancer

Scientists discover human DNA that act as a traitor to body's defences

Stalk structure of Mx protein restrains components of influenza virus in infected cells

Research reveals therapeutic benefit of ACTH in treatment of osteonecrosis

Researchers find Alzheimer's pathology to originate from Amyloid-Beta oligomers in the brain

Study examines world-wide use of HSCT

Potential new treatment for osteonecrosis

Transplanted pig cells may bring relief from insulin injections in type I diabetics

NCCTG to conduct Phase II study of brostallicin in combination with cisplatin for mTNBC cancer

Researchers link vitamin D deficiency to chronic fatigue in post-TBI sufferers

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News